Big Gain For Can-Fite BioPharma Ltd.
Fri, Nov 29, 2019 at 05:30 PM
Can-Fite BioPharma Ltd. (CANF:NYSEMKT) shot up at $3.54, representing a gain of 37.7%. The stock appeared on our News Catalysts scanner on Tue 19 Nov 19 at 06:17 PM in the 'PRIVATE PLACEMENT' category. From Thu 07 Nov 19, the stock recorded 71.43% Up Days and 40.00% Green Days
The stock spiked on Thu 17 Oct 19 at $4 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About Can-Fite BioPharma Ltd. (CANF:NYSEMKT)
Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.
Top 10 Gainers:
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 64.66%
- Cancer Genetics, Inc. (CGIX:NASDAQ), 58.17%
- Pintec Technology Holdings Limited (PT:NASDAQ), 48.89%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 37.74%
- Stealth BioTherapeutics Corp (MITO:NASDAQ), 35.65%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 34.33%
- Sequans Communications S.A. (SQNS:NYSE), 33.19%
- SORL Auto Parts, Inc. (SORL:NASDAQ), 30%
- TransAtlantic Petroleum Ltd. (TAT:NYSEMKT), 25.49%
- Novavax, Inc. (NVAX:NASDAQ), 23.1%